These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20105186)

  • 1. The effect of oxandrolone on body proportions and body composition in growth hormone-treated girls with Turner syndrome.
    Menke LA; Sas TC; Zandwijken GR; de Ridder MA; Stijnen T; de Muinck Keizer-Schrama SM; Otten BJ; Wit JM
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):212-9. PubMed ID: 20105186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the weak androgen oxandrolone on psychological and behavioral characteristics in growth hormone-treated girls with Turner syndrome.
    Menke LA; Sas TC; Visser M; Kreukels BP; Stijnen T; Zandwijken GR; de Muinck Keizer-Schrama SM; Otten BJ; Wit JM; Cohen-Kettenis PT
    Horm Behav; 2010 Mar; 57(3):297-305. PubMed ID: 20053349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome.
    Menke LA; Sas TC; de Muinck Keizer-Schrama SM; Zandwijken GR; de Ridder MA; Odink RJ; Jansen M; Delemarre-van de Waal HA; Stokvis-Brantsma WH; Waelkens JJ; Westerlaken C; Reeser HM; van Trotsenburg AS; Gevers EF; van Buuren S; Dejonckere PH; Hokken-Koelega AC; Otten BJ; Wit JM
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1151-60. PubMed ID: 20061421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of oxandrolone on voice frequency in growth hormone-treated girls with Turner syndrome.
    Menke LA; Sas TC; van Koningsbrugge SH; de Ridder MA; Zandwijken GR; Boersma B; Dejonckere PH; de Muinck Keizer-Schrama SM; Otten BJ; Wit JM
    J Voice; 2011 Sep; 25(5):602-10. PubMed ID: 20971614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Carbohydrate metabolism in patients with Turner syndrome. The effect of therapy with growth hormone, oxandrolone and a combination of both].
    Starzyk J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(2):79-84. PubMed ID: 15996336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of growth hormone and 17beta-oestradiol treatment on metabolism and body composition in girls with Turner syndrome.
    Gravholt CH; Hjerrild BE; Naeraa RW; Engbaek F; Mosekilde L; Christiansen JS
    Clin Endocrinol (Oxf); 2005 May; 62(5):616-22. PubMed ID: 15853835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of oxandrolone in growth hormone-treated girls with Turner syndrome: evidence from recent studies and recommendations for use.
    Sas TC; Gault EJ; Bardsley MZ; Menke LA; Freriks K; Perry RJ; Otten BJ; de Muinck Keizer-Schrama SM; Timmers H; Wit JM; Ross JL; Donaldson MD
    Horm Res Paediatr; 2014; 81(5):289-97. PubMed ID: 24776783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of previous oxandrolone treatment in adult women with Turner syndrome.
    Freriks K; Sas TC; Traas MA; Netea-Maier RT; den Heijer M; Hermus AR; Wit JM; van Alfen-van der Velden JA; Otten BJ; de Muinck Keizer-Schrama SM; Gotthardt M; Dejonckere PH; Zandwijken GR; Menke LA; Timmers HJ
    Eur J Endocrinol; 2013 Jan; 168(1):91-9. PubMed ID: 23076845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone therapy in Turner's syndrome: an update on final height. Genentech National Cooperative Study Group.
    Rosenfeld RG
    Acta Paediatr Suppl; 1992 Sep; 383():3-6; discussion 7. PubMed ID: 1458013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of oxandrolone treatment in childhood on neurocognition, quality of life and social-emotional functioning in young adults with Turner syndrome.
    Freriks K; Verhaak CM; Sas TC; Menke LA; Wit JM; Otten BJ; de Muinck Keizer-Schrama SM; Smeets DF; Netea-Maier RT; Hermus AR; Kessels RP; Timmers HJ
    Horm Behav; 2015 Mar; 69():59-67. PubMed ID: 25562712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome.
    Zeger MP; Shah K; Kowal K; Cutler GB; Kushner H; Ross JL
    Horm Res Paediatr; 2011; 75(1):38-46. PubMed ID: 20733274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcome in Turner syndrome.
    Parvin M; Roche E; Costigan C; Hoey HM
    Ir Med J; 2004 Jan; 97(1):12, 14-5. PubMed ID: 15055914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comments on 'Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome' by Zeger et al., pp. 39-47, this issue.
    Menke LA; Sas TC; Wit JM
    Horm Res Paediatr; 2011; 75(1):47-8. PubMed ID: 21051854
    [No Abstract]   [Full Text] [Related]  

  • 14. Acceleration of growth in Turner syndrome patients treated with growth hormone: summary of three-year results.
    Rosenfeld RG
    J Endocrinol Invest; 1989; 12(8 Suppl 3):49-51. PubMed ID: 2681348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
    Gravholt CH; Naeraa RW; Brixen K; Kastrup KW; Mosekilde L; Jørgensen JO; Christiansen JS
    Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age.
    Stahnke N; Keller E; Landy H;
    J Pediatr Endocrinol Metab; 2002 Feb; 15(2):129-38. PubMed ID: 11874177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxandrolone for growth hormone-treated girls aged up to 18 years with Turner syndrome.
    Mohamed S; Alkofide H; Adi YA; Amer YS; AlFaleh K
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth promotion and Turner-specific bone age after therapy with growth hormone and in combination with oxandrolone: when should therapy be started in Turner syndrome?
    Joss EE; Mullis PE; Werder EA; Partsch CJ; Sippell WG
    Horm Res; 1997; 47(3):102-9. PubMed ID: 9050948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of oxandrolone and timing of oral ethinylestradiol initiation on pubertal progression, height velocity and bone maturation in the UK Turner study.
    Perry RJ; Gault EJ; Paterson WF; Dunger DB; Donaldson MD
    Horm Res Paediatr; 2014; 81(5):298-308. PubMed ID: 24751470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Turner syndrome.
    Ranke MB
    Eur J Endocrinol; 1999 Sep; 141(3):216-7. PubMed ID: 10474117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.